Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
Completed
- Conditions
- Infertility, Female
- Interventions
- Drug: rFSH
- Registration Number
- NCT05130125
- Lead Sponsor
- LG Chem
- Brief Summary
A multicenter, retrospective cohort observational study to evaluate the effectiveness and safety of fresh or frozen embryo transfer after ovarian hyperstimulation (administration of rFSH or HP-hMG alone or co-administration of rFSH and HP-hMG)
- Detailed Description
A multicenter, retrospective cohort observational study to evaluate the effectiveness and safety of fresh or frozen embryo transfer after ovarian hyperstimulation (administration of rFSH or HP-hMG alone or co-administration of rFSH and HP-hMG) to infertile female patients undergoing assisted reproductive technology to controlled ovarian hyperstimulation
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 1166
Inclusion Criteria
- First IVF-ET cycle patients
Exclusion Criteria
Poor ovarian responder
- At least two of the following three features must be present: (i) Advanced maternal age (≥ 40 years) or any other risk factor for Poor ovarian response (POR); (ii) A previous POR (≤ 3 oocytes with a conventional stimulation protocol); (iii) An abnormal ovarian reserve test (i.e. AFC < 5-7 follicles or AMH < 0.5-1.1 ng/mL)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description fresh embryo rFSH fresh embryo transfer after ovarian hyperstimulation frozen embryo rFSH frozen embryo transfer after ovarian hyperstimulation
- Primary Outcome Measures
Name Time Method Number of Oocytes average of 14 days Counting number of Oocytes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHA Fertility Hospital
🇰🇷Gyeonggi-do, Korea, Republic of